The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model

Aliz Bozó; Marianna Domán; László Majoros; Gábor Kardos; István Varga; Renátó Kovács

doi:10.1007/s12275-016-6298-y

Articles

Page Path: HOME > J. Microbiol > Volume 54(11); 2016 > Article

Journal Article
The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model: Aliz Bozó ¹, Marianna Domán ¹, László Majoros ¹, Gábor Kardos ¹, István Varga ², Renátó Kovács ¹; Journal of Microbiology 2016;54(11):753-760.
DOI: https://doi.org/10.1007/s12275-016-6298-y
Published online: October 29, 2016

¹Department of Medical Microbiology, Faculty of Medicine, University of Debrecen, Debrecen 4032, Hungary, ²Department of Periodontology, Faculty of Dentistry, University of Debrecen, Debrecen 4032, Hungary¹Department of Medical Microbiology, Faculty of Medicine, University of Debrecen, Debrecen 4032, Hungary, ²Department of Periodontology, Faculty of Dentistry, University of Debrecen, Debrecen 4032, Hungary

Corresponding author: Renátó Kovács , Tel: -,

Received: 22 June 2016 • Revised: 29 August 2016 • Accepted: 1 September 2016

prev next

45 Views
0 Download
27 Crossref
32 Scopus

Full Article

Abstract

Farnesol is a quorum-sensing molecule that inhibits biofilm formation in Candida albicans. Previous in vitro data suggest that, in combination with certain antifungals, farnesol may have an adjuvant anti-biofilm agent. However, the in vivo efficacy of farnesol is very questionable. Therefore, the in vitro and in vivo activity of fluconazole combined with farnesol was evaluated against C. albicans biofilms using fractional inhibitory concentration index (FICI) determination, time-kill experiments and a murine vulvovaginitis model. The median biofilm MICs of fluconazole-sensitive C. albicans isolates ranged between 4 -> 512 mg/L and 150–300 μM for fluconazole and farnesol, respectively. These values were 512 -> 512 mg/L and > 300 μM for fluconazole-resistant clinical isolates. Farnesol decreased the median MICs of fluconazole by 2-64-fold for biofilms. Based on FICI, synergistic interaction was observed only in the case of the sessile SC5314 reference strain (FICIs: 0.16–0.27). In time-kill studies, only the 512 mg/L fluconazole and 512 mg/L fluconazole + 75 μM farnesol reduced biofilm mass significantly at each time point in the case of all isolates. The combination reduced the metabolic activity of biofilms for all isolates in a concentration- and time-dependent manner. Our findings revealed that farnesol alone was not protective in a murine vulvovaginitis model. Farnesol was not beneficial in combination with fluconazole for fluconazole-susceptible isolates, but partially increased fluconazole activity against one fluconazole- resistant isolate, but not the other one.

Keywords: time-kill experiment;FIC index;murine vulvovaginitis;fluconazole-resistant;synergy

Figure & Data

References

Citations

Citations to this article as recorded by

Exploring the Potential of Farnesol as a Novel Antifungal Drug and Related Challenges
Dongming Zheng, Linlan Yang, Yuxin Bai, Jiangyan Yong, Yan Li
Current Infectious Disease Reports.2024; 26(4): 123. CrossRef
Total transcriptome response for tyrosol exposure in Aspergillus nidulans
Ágnes Jakab, Kinga Csillag, Károly Antal, Imre Boczonádi, Renátó Kovács, István Pócsi, Tamás Emri
Fungal Biology.2024; 128(2): 1664. CrossRef
Combination of Farnesol with Common Antifungal Drugs: Inhibitory Effect against Candida Species Isolated from Women with RVVC
Fatemeh Nikoomanesh, Mahsa Falahatinejad, Lucia Černáková, André Luis Souza dos Santos, Shahla Roudbar Mohammadi, Mitra Rafiee, Célia Fortuna Rodrigues, Maryam Roudbary
Medicina.2023; 59(4): 743. CrossRef
Antifungal Activity and Type of Interaction of Melissa officinalis Essential Oil with Antimycotics against Biofilms of Multidrug-Resistant Candida Isolates from Vulvovaginal Mucosa
Marina Ranđelović, Marina Dimitrijević, Suzana Otašević, Ljiljana Stanojević, Milica Išljamović, Aleksandra Ignjatović, Valentina Arsić-Arsenijević, Zorica Stojanović-Radić
Journal of Fungi.2023; 9(11): 1080. CrossRef
Application of natamycin and farnesol as bioprotection agents to inhibit biofilm formation of yeasts and foodborne bacterial pathogens in apple juice processing lines
María del Rosario Agustín, María Clara Tarifa, María Soledad Vela-Gurovic, Lorena Inés Brugnoni
Food Microbiology.2023; 109: 104123. CrossRef
Hexyl-Aminolevulinate Ethosomes: a Novel Antibiofilm Agent Targeting Zinc Homeostasis in Candida albicans
Yingzhe Wang, Wei Long, Feiyin Zhang, Meimei Zhang, Kang Zeng, Xiaoliang Zhu, Gustavo H. Goldman
Microbiology Spectrum.2022;[Epub] CrossRef
Farnesol Boosts the Antifungal Effect of Fluconazole and Modulates Resistance in Candida auris through Regulation of the CDR1 and ERG11 Genes
Jaroslava Dekkerová, Lucia Černáková, Samuel Kendra, Elisa Borghi, Emerenziana Ottaviano, Birgit Willinger, Helena Bujdáková
Journal of Fungi.2022; 8(8): 783. CrossRef
Application of Natamycin and Farnesol as Biocontrol Agents of Multi-Species Biofilms on Industrial Surfaces in Apple Juice
María del Rosario Agustín, Maria Clara Tarifa, Maria Soledad Vela-Gurovic, Lorena Ines Brugnoni
SSRN Electronic Journal .2022;[Epub] CrossRef
Transcriptional Profiling of the Candida auris Response to Exogenous Farnesol Exposure
Ágnes Jakab, Noémi Balla, Ágota Ragyák, Fruzsina Nagy, Fruzsina Kovács, Zsófi Sajtos, Zoltán Tóth, Andrew M. Borman, István Pócsi, Edina Baranyai, László Majoros, Renátó Kovács, Aaron P. Mitchell
mSphere.2021;[Epub] CrossRef
Farnesol: An approach on biofilms and nanotechnology
Adelaide Fernandes Costa, Lívia do Carmo Silva, Andre Correa Amaral
Medical Mycology.2021; 59(10): 958. CrossRef
Modulating the Antifungal Activity of Antimycotic Drugs with Farnesol
N. P. Sachivkina, A. N. Senyagin, I. V. Podoprigora, D. G. Brown, V. V. Vissarionova
Drug development & registration.2021; 10(4): 162. CrossRef
In vivo antifungal activities of farnesol combined with antifungal drugs against murine oral mucosal candidiasis
Chengxi Li, Zheng Xu, Siqi Liu, Yun Huang, Wei Duan, Xin Wei
Biofouling.2021; 37(8): 818. CrossRef
Analysis of biofilm formation bySporothrix schenckii
Rocío Sánchez-Herrera, Lérida Liss Flores-Villavicencio, Juan Luis Pichardo-Molina, José Pedro Castruita-Domínguez, Xochilt Aparicio-Fernández, Myrna Sabanero López, Julio Cesar Villagómez-Castro
Medical Mycology.2021; 59(1): 31. CrossRef
Antifungal activity of farnesol incorporated in liposomes and associated with fluconazole
Camila Fonseca Bezerra, José Geraldo de Alencar Júnior, Rosilaine de Lima Honorato, Antonia Thassya Lucas dos Santos, Josefa Carolaine Pereira da Silva, Taís Gusmão da Silva, Antonio Linkoln Alves Borges Leal, Janaína Esmeraldo Rocha, Thiago Sampaio de Fr
Chemistry and Physics of Lipids.2020; 233: 104987. CrossRef
Optimum Inhibition of Amphotericin-B-Resistant Candida albicans Strain in Single- and Mixed-Species Biofilms by Candida and Non-Candida Terpenoids
Hidaya F. Z. Touil, Kebir Boucherit, Zahia Boucherit-Otmani, Ghalia Kohder, Mohamed Madkour, Sameh S. M. Soliman
Biomolecules.2020; 10(2): 342. CrossRef
In vitro and in vivo Effect of Exogenous Farnesol Exposure Against Candida auris
Fruzsina Nagy, Eszter Vitális, Ágnes Jakab, Andrew M. Borman, Lajos Forgács, Zoltán Tóth, László Majoros, Renátó Kovács
Frontiers in Microbiology.2020;[Epub] CrossRef
Fungal Quorum-Sensing Molecules: A Review of Their Antifungal Effect against Candida Biofilms
Renátó Kovács, László Majoros
Journal of Fungi.2020; 6(3): 99. CrossRef
Fungal infection models: Current progress ofex vivomethods
Priscilla Maciel Quatrin, Daiane Flores Dalla Lana, Taís Fernanda Andrzejewski Kaminski, Alexandre Meneghello Fuentefria
Mycoses.2019; 62(10): 860. CrossRef
Effect of quorum sensing molecules and natamycin on biofilms of Candida tropicalis and other yeasts isolated from industrial juice filtration membranes
M.d.R. Agustín, F.R. Viceconte, M.S. Vela Gurovic, A. Costantino, L.I. Brugnoni
Journal of Applied Microbiology.2019; 126(6): 1808. CrossRef
Farnesol inhibits planktonic cells and antifungal-tolerant biofilms of Trichosporon asahii and Trichosporon inkin
Rossana de Aguiar Cordeiro, Lívia Maria Galdino Pereira, José Kleybson de Sousa, Rosana Serpa, Ana Raquel Colares Andrade, Fernando Victor Monteiro Portela, Antônio José de Jesus Evangelista, Jamille Alencar Sales, Ana Luiza Ribeiro Aguiar, Patrícia Bruna
Medical Mycology.2019; 57(8): 1038. CrossRef
In Vivo Applicability of Neosartorya fischeri Antifungal Protein 2 (NFAP2) in Treatment of Vulvovaginal Candidiasis
Renátó Kovács, Jeanett Holzknecht, Zoltán Hargitai, Csaba Papp, Attila Farkas, Attila Borics, Lilána Tóth, Györgyi Váradi, Gábor K. Tóth, Ilona Kovács, Sandrine Dubrac, László Majoros, Florentine Marx, László Galgóczy
Antimicrobial Agents and Chemotherapy.2019;[Epub] CrossRef
Biofilms and vulvovaginal candidiasis
Carmen Rodríguez-Cerdeira, Miguel Carnero Gregorio, Alberto Molares-Vila, Adriana López-Barcenas, Gabriella Fabbrocini, Brunilda Bardhi, Ardiana Sinani, Elena Sánchez-Blanco, Roberto Arenas-Guzmán, Rigoberto Hernandez-Castro
Colloids and Surfaces B: Biointerfaces.2019; 174: 110. CrossRef
Photodynamic Inactivation Potentiates the Susceptibility of Antifungal Agents against the Planktonic and Biofilm Cells of Candida albicans
Mu-Ching Huang, Mandy Shen, Yi-Jhen Huang, Hsiao-Chi Lin, Chin-Tin Chen
International Journal of Molecular Sciences.2018; 19(2): 434. CrossRef
Antimicrobial photodynamic therapy as a new approach for the treatment of vulvovaginal candidiasis: preliminary results
Maria Eugênia Simões Onofre de Santi, Renato Araujo Prates, Cristiane Miranda França, Rúbia Garcia Lopes, Aline Silva Sousa, Luis Rodolfo Ferreira, Sandra Kalil Bussadori, Adjaci Uchoa Fernandes, Alessandro Melo Deana
Lasers in Medical Science.2018; 33(9): 1925. CrossRef
In vitro antifungal susceptibility patterns of planktonic and sessile Candida kefyr clinical isolates
Fruzsina Nagy, Aliz Bozó, Zoltán Tóth, Lajos Daróczi, László Majoros, Renátó Kovács
Medical Mycology.2018; 56(4): 493. CrossRef
The Structure-Activity Relationship of Pterostilbene Against Candida albicans Biofilms
Dan-Dan Hu, Ri-Li Zhang, Yong Zou, Hua Zhong, En-Sheng Zhang, Xiang Luo, Yan Wang, Yuan-Ying Jiang
Molecules.2017; 22(3): 360. CrossRef
Antifungal activity of tyrosol and farnesol used in combination against Candida species in the planktonic state or forming biofilms
D.R. Monteiro, L.S. Arias, R.A. Fernandes, L.F. Deszo da Silva, M.O.V.F. de Castilho, T.O. da Rosa, A.P.M. Vieira, F.G. Straioto, D.B. Barbosa, A.C.B. Delbem
Journal of Applied Microbiology.2017; 123(2): 392. CrossRef

Cite this Article

Cite this Article: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model

J. Microbiol. 2016;54(11):753-760. Published online October 29, 2016

DOI: https://doi.org/10.1007/s12275-016-6298-y

Related articles